Edmond De Rothschild Holding S.A. Denali Therapeutics Inc. Transaction History
Edmond De Rothschild Holding S.A.
- $6.36 Billion
- Q3 2025
A detailed history of Edmond De Rothschild Holding S.A. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 205,680 shares of DNLI stock, worth $3.59 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
205,680
Previous 205,680
-0.0%
Holding current value
$3.59 Million
Previous $2.88 Million
3.79%
% of portfolio
0.05%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding DNLI
# of Institutions
267Shares Held
137MCall Options Held
219KPut Options Held
107K-
Black Rock Inc. New York, NY13.2MShares$230 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$228 Million0.0% of portfolio
-
Baillie Gifford & CO12.3MShares$215 Million0.19% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.64MShares$98.3 Million0.05% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL5.47MShares$95.3 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.34B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...